Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
Clinical trial NCT02410356 · TERMINATED
Trial details
- NCT number
- NCT02410356
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-30
- Primary completion
- 2016-02-29
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.